tiprankstipranks
Tauns Laboratories, Inc. (JP:197A)
:197A
Japanese Market
197A
Tauns Laboratories, Inc.
RESEARCH TOOLSreports

Tauns Laboratories, Inc. (197A) Financial Statements

Compare
0 Followers

Tauns Laboratories, Inc. Financial Overview

Tauns Laboratories, Inc.'s market cap is currently ¥56.30B. The company's EPS TTM is ¥; its P/E ratio is 7.76; and it has a dividend yield of 5.09%. Tauns Laboratories, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22
Income Statement
Total Revenue¥ 18.63B¥ 18.43B¥ 15.67B¥ 17.46B
Gross Profit¥ 12.33B¥ 12.50B¥ 8.79B¥ 14.29B
Operating Income¥ 8.27B¥ 8.03B¥ 4.97B¥ 11.19B
EBITDA¥ 9.02B¥ 8.65B¥ 5.32B¥ 8.55B
Net Income¥ 6.32B¥ 5.77B¥ 3.03B¥ 4.48B
Balance Sheet
Cash & Short-Term Investments¥ 9.27B¥ 9.42B¥ 1.24B¥ 6.35B
Total Assets¥ 36.52B¥ 29.26B¥ 18.81B¥ 20.88B
Total Debt¥ 14.42B¥ 9.54B¥ 6.47B¥ 4.90B
Net Debt¥ 5.16B¥ 114.11M¥ 5.22B¥ -1.45B
Total Liabilities¥ 19.10B¥ 15.59B¥ 10.32B¥ 13.52B
Stockholders' Equity¥ 17.42B¥ 13.67B¥ 8.49B¥ 7.36B
Cash Flow
Free Cash Flow¥ 2.14B¥ 5.97B¥ -4.32B¥ 8.39B
Operating Cash Flow¥ 6.82B¥ 9.94B¥ -3.16B¥ 10.69B
Investing Cash Flow¥ -9.26B¥ -4.11B¥ -1.62B¥ -2.68B
Financing Cash Flow¥ 2.28B¥ 2.36B¥ -330.20M¥ -3.66B
Currency in JPY

Tauns Laboratories, Inc. Earnings and Revenue History

Income Statement >

Tauns Laboratories, Inc. Debt to Assets

Balance Sheet >

Tauns Laboratories, Inc. Cash Flow

Cash Flow >

Tauns Laboratories, Inc. Forecast EPS vs Actual EPS

Earnings >